Morning Briefing
Summaries of health policy coverage from major news organizations
Democratic Lawmakers Ask Hepatitis C Drugmaker To Justify Price
The pill's developer, Gilead Sciences, sells it for $1,000 per pill.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.